Delivery Order SPE2DB20D2001-SPE2DB24FM28L
- Not listed
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to support the Medical Supply Chain program of the Defense Logistics Agency (DLA). The contract, awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a firm fixed-price delivery order valued at $5,761.28. The contract has an ultimate completion date of May 18, 2023. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide Repatha (evolocumab) 140 mg/mL SureClick injector pens. The $5,111.84 award was made by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of November 16, 2021. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as the...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick injectors to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distributors in the world. The contract has a ceiling value of $4,807.89 and is a firm fixed-price delivery order with an ultimate completion date of April 25, 2024. Amerisourcebergen also...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick injectors to the Defense Logistics Agency (DLA). The $3,313.54 firm fixed-price delivery order contract was awarded on December 23, 2024 to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 24, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick autoinjectors to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract, valued at $1,814.17, was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distribution company that serves as a prime contractor for various government agencies. The contract is a firm-fixed price Delivery Order under an Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick Autoinjector, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $1,216.21 firm-fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract has an ultimate completion date of May 16, 2023 and was awarded on May 15, 2023. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Cencora, Inc....
- This federal contract award is for the delivery of Repatha 140 mg/ml SureClick medication to the Defense Logistics Agency (DLA). The $7,167.57 firm-fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of November 8, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award is for the delivery of Repatha (140 mg/mL) SureClick injectors, a specialty medication used to treat cardiovascular conditions. The $1,355.76 delivery order was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds a $999,999,999 Indefinite...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClick Autoinjector, a specialty pharmaceutical product, to the Defense Logistics Agency (DLA). The $34,127.23 firm-fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and subsidiary of Cencora, Inc. The award has an ultimate completion date of January 4, 2023 and was made without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a...
- This federal contract award is for the delivery of Repatha 140 mg/mL SureClick autoinjector medication to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense. The contract, valued at $4,067.28, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on a firm-fixed price basis. The contract does not have a set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- SPE2DB20D2001Indefinite Delivery Contract
- SPE2DB20D2001-SPE2DB24FM28LDelivery Order
This federal contract award is for the delivery of Repatha 140 mg/mL SureClick injector pens to the Defense Logistics Agency (DLA). The contract, valued at $1,016.82, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. This delivery order is part of a larger Indefinite Delivery Contract (IDC) between Cencora, Inc. (doing business as Amerisourcebergen) and the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through December 2025. The IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular delivery order does not have a set-aside designation, indicating it was awarded through full and open competition.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.0k | 10/25/23 |